Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Wilkinson

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Respiratory Research|February 21, 2018
Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPDKristoffer Ostridge, Nicholas P Williams, Viktoriya Kim, et al.
The European Respiratory Journal|October 14, 2017
Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohortViktoriya L Kim, Ngaire A Coombs, Karl J Staples, et al.
The Lancet. Respiratory Medicine|November 15, 2020
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialPhillip D Monk, Richard J Marsden, Victoria J Tear, et al.
ERJ Open Research|August 13, 2019
A specific proteinase 3 activity footprint in α<sub>1</sub>-antitrypsin deficiencyPaul R Newby, Diana Crossley, Helena Crisford, et al.
Plos One|October 5, 2016
Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36Grace E Cooper, Zoe C Pounce, Joshua C Wallington, et al.
Thorax|April 23, 2017
A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPDTom M A Wilkinson, Emmanuel Aris, Simon Bourne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2015
A novel lung explant model for the ex vivo study of efficacy and mechanisms of anti-influenza drugsBen Nicholas, Karl J Staples, Stefan Moese, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Research priorities for exacerbations of COPDJaber S Alqahtani, Julian Aquilina, Mona Bafadhel, et al.
Respiratory Research|September 23, 2020
Inflammatory phenotyping predicts clinical outcome in COVID-19H Burke, A Freeman, D C Cellura, et al.
Vaccine|August 27, 2019
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trialTom M A Wilkinson, Stuart Schembri, Christopher Brightling, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Respiratory Research|February 21, 2018
Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPDKristoffer Ostridge, Nicholas P Williams, Viktoriya Kim, et al.
The European Respiratory Journal|October 14, 2017
Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohortViktoriya L Kim, Ngaire A Coombs, Karl J Staples, et al.
The Lancet. Respiratory Medicine|November 15, 2020
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialPhillip D Monk, Richard J Marsden, Victoria J Tear, et al.
ERJ Open Research|August 13, 2019
A specific proteinase 3 activity footprint in α<sub>1</sub>-antitrypsin deficiencyPaul R Newby, Diana Crossley, Helena Crisford, et al.
Plos One|October 5, 2016
Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36Grace E Cooper, Zoe C Pounce, Joshua C Wallington, et al.
Thorax|April 23, 2017
A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPDTom M A Wilkinson, Emmanuel Aris, Simon Bourne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2015
A novel lung explant model for the ex vivo study of efficacy and mechanisms of anti-influenza drugsBen Nicholas, Karl J Staples, Stefan Moese, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Research priorities for exacerbations of COPDJaber S Alqahtani, Julian Aquilina, Mona Bafadhel, et al.
Respiratory Research|September 23, 2020
Inflammatory phenotyping predicts clinical outcome in COVID-19H Burke, A Freeman, D C Cellura, et al.
Vaccine|August 27, 2019
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trialTom M A Wilkinson, Stuart Schembri, Christopher Brightling, et al.
Pageof 12